Aeromics

About Aeromics

Aeromics, Inc. is a clinical-stage pharmaceutical company developing an intravenously administered aquaporin-4 (AQP4) inhibitor (AER-271) for severe, acute ischemic stroke that will prevent or arrest brain swelling (cerebral edema) following an ischemic event.

By preventing brain swelling AER-271 will significantly improve survival following an ischemic brain event, lead to better outcomes and more complete and faster recovery and reduce the need for more invasive treatments such as decompressive craniectomy.

Aeromics is currently investigating the pharmacokinetics, safety and tolerability of AER-271 in a Phase 1 clinical trial.

Write Your Reviews

Writing great reviews may help others discover the places that are just apt for them. Here are a few tips to write a good review:

3 Star

Be the First One To Review This Listing!!!

Company Info

Year Founded
Number of Employees 50 - 99
Minimal Budget $10,000 - $25,000

Our Location

11000 Cedar Ave #270, Cleveland , Ohio 44106 , United States
View Map

Aeromics

About Aeromics

Write Your Reviews

Company Info

Our Location

What service do you need? DokaLink will help you

#1 Business Directory and Service Provider

Free support: +1 757 447 6360 | Email:

Top Category

Trending Category

HELP & SUPPORT

Get In Touch

SOCIAL MEDIA